Beta adrenergic blocking drugs were found to be effective hypotensive agents in the long-term treatment of patients with hypertension. In 40 % of patients they appeared to be an extremely satisfactory antihypertensive agent. The fall in blood pressure was confirmed in a double blind study which also indicated that propranolol, prindolol, alprenolol and MK 950 (timolol) had similar antihypertensive properties. Propranolol and timolol reduced the pulse rate more than prindolol and alprenolol but the fall in blood pressure induced by the four drugs was not significantly different.
Summary
Beta adrenergic blocking drugs were found to be effective hypotensive agents in the long-term treatment of patients with hypertension. In 40 % of patients they appeared to be an extremely satisfactory antihypertensive agent. The fall in blood pressure was confirmed in a double blind study which also indicated that propranolol, prindolol, alprenolol and MK 950 (timolol) had similar antihypertensive properties. Propranolol and timolol reduced the pulse rate more than prindolol and alprenolol but the fall in blood pressure induced by the four drugs was not significantly different. The incidence of volunteered side effects was low, but when questioned specifically a large number of patients has disturbance of their dream pattern. This was more frequent and severe with prindolol and alprenolol. In this study bronchospasm was associated with the use of propranolol and timolol but not with that of prindolol and alprenolol.
In general, there is little difference between the various beta adrenergic blocking drugs in the treatment of hypertension, but in a few patients one or other may have advantages over the remainder. The dose ratios of the four drugs closely reflected their reported potency in producing beta adrenergic blockade. However, their exact mechanism of action is unknown, though it is probable that part of their effect is mediated via the central nervous system. BETA adrenergic blocking drugs are a significant advance in the control of hypertension. If used in large doses in combination with a thiazide diuretic they produce a fall in blood pressure and a degree of blood pressure control that compares favourably with other first line antihypertensive drugs (Prichard and Giltam, 1969; Morgan et al., 1972 ; Zacharias and Cowen, 1970) .
A large number of beta adrenergic blocking drugs now exist. Chemically these have certain structural elements in common ( Fig. 1 ) but vary in their potency and their biological effects (Guidicelli, Schmitt and Boissier, 1969; Wilson et al., 1968; Dunlop and Shanks, 1969; Vohra, Dowling and Sloman, 1969) . During the last 3 years four different beta blocking drugs (prindolol, propranolol, alprenolol and (Table 2) . Overall between 40-60% of patients benefited from this form of therapy.
The incidence of side effects for each beta blocking drug was similar, but the pattern was different. Prindolol and alprenolol were associated with a high incidence of dreams and nightmares whereas bronchospasm was only seen in patients given propran4lol or timolol (Table 3 ). In most cases the side effects were of a minor nature and treatment had to be ceased because of side effects in less than 10% of patients (Table 2) .
Double-blind crossover trial
Twenty patients commenced the double-blind evaluation of the four beta adrenergic blocking agents and all except patients 2 and 4 completed the trial. These two patients who were female have not been included in the analysis. The eighteen patients who form the basis of the trial were males with serum creatinine below 1 8 mg %.
The full results are indicated in Table 4 The pulse rate in patients on beta adrenergic blocking drugs fell below the control values but the depression was greatest with propranolol and timolol. The pulse rates on these last two drugs were similar and the pulse rate on prindolol did not differ from that on alprenolol.
The side effects in this group of patients are indicated in Table 6 . The incidence of dreams frequently of a bizarre or nightmarish quality was high when the patients were specifically questioned. These appeared to be most frequent and severe in patients taking prindolol. However, they also occurred during treatment with the other beta adrenergic blocking drugs, though they were least frequent on timolol. Three patients developed bronchospasm while on propranolol and timolol, but the same patients were free of this while taking prindolol or alprenolol. (Table 7 ). An occasional patient resistant to propranolol responded to prindolol (patients 30 and 32), and other minor differences in response were noted (patients 29 and 34). In three patients (Table 8) , prindolol was ceased due to severe incapacitating side effects; the blood pressure response had been good in one of these and propranolol was able to be used successfully. In the other two, propranolol was able to be used without side effects but did not successfully lower the blood pressure. Likewise in two patients propranolol had to be ceased because of bronchospasm and prindolol was able to be used without this effect (Table 8) .
Discussion
The results presented in this study indicate that each of the four beta adrenergic receptor blocking drugs produced a significant fall in blood pressure in approximately 65% of patients with moderate to severe hypertension. This fall occurred promptly and was usually present within 2 weeks; likewise when the beta adrenergic blocking drugs were ceased the blood pressure rapidly returned to its pre-treatment level. This contrasts with the slower onset of the antihypertensive effect reported by Prichard and Giltam (1969) , but is similar to the findings of WaalManning (1970). While we found a significant hypotensive effect with the beta adrenergic blocking drugs, it should be emphasized that approximately 35% of hypertensive patients did not respond even if high doses were given for a prolonged period.
Although all four beta adrenergic receptor antagonists used in this study were structurally related to isoprenaline (Fig. 1) , the different ring substituents produce considerable changes in beta receptor blocking potency. In all patients the dose of beta adrenergic blocking drug needed to produce a fall in blood pressure was much larger than the beta blocking dose. However, the ratio of the dosage needed to produce an antihypertensive effect was similar to the relative beta adrenergic blocking potency of the four drugs. While the falls in blood pressure may be in part due to depression of cardiac output, the high incidence of central nervous system side effects and the relative lack of postural hypotension with these drugs suggest that an action on central vasometer centres may also be important (Morgan et al., 1972) . If these drugs do indeed reduce blood pressure by an action at a central site, then the variation in dose required for different drugs may reflect the ease with which these substances enter the brain. The differing incidence of central nervous system side effects supports this suggestion.
In the double-blind crossover studies no one drug appeared to have particular superiority. Individual patients occasionally responded better to one or other drug although there were no statistically significant differences in the effects of the various agents. In general, if a patient had a good response with one drug this also occurred with the other three. There was no difference in the magnitude of the antihypertensive action but propranolol and timolol reduced the pulse rate more than alprenolol or prindolol.
In patients resistant to one beta blocking drug changing to another did not help in controlling the patient's blood pressure. This also suggests that the drugs are acting in a similar fashion despite differences in structure and potency. It 
